Physiol. Genomics Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 38: 226-232, 2009. First published May 26, 2009; doi:10.1152/physiolgenomics.00011.2009 Free Article
1094-8341/09 $8.00
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
38/2/226    most recent
00011.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Vogel, H.
Right arrow Articles by Scherneck, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, H.
Right arrow Articles by Scherneck, S.
Received 16 January 2009; accepted in final form 22 May 2009.
Physiological Genomics 38:226-232 (2009)
1094-8341/09 $8.00 © 2009 American Physiological Society

Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1

Heike Vogel 1, Matthias Nestler 1, Franz Rüschendorf 2, Marcel-Dominique Block 1, Sina Tischer 1, Reinhart Kluge 1, Annette Schürmann 1, Hans-Georg Joost 1 and Stephan Scherneck 1

1 Department of Pharmacology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal
2 Max Delbrück Centre for Molecular Medicine, Berlin-Buch, Berlin, Germany

New Zealand obese (NZO) mice present a metabolic syndrome of obesity, insulin resistance, and diabetes. To identify chromosomal segments associated with these traits, we intercrossed NZO mice with the lean and diabetes-resistant C57BL/6J (B6) strain. Obesity and hyperglycemia in the (NZOxB6)F2 intercross population were predominantly due to a broad quantitative trait locus (QTL) on chromosome 1 (Nob3; logarithm of the odds score 16.1, 16.0, 4.0 for body weight, body fat, and blood glucose, respectively), producing a difference between genotypes of 12.7 or 5.2 g of body weight and 12.0 or 4.0 g of body fat in females or males, respectively. In addition, significant QTL on chromosomes 3 and 13 and suggestive QTL on chromosomes 4, 6, 9, 12, 14, and 19 contributed to the obese phenotype. Distal chromosome 5 was significantly linked with plasma cholesterol (LOD score 10.7). Introgression of two segments of Nob3 into B6 confirmed the adipogenic effect of the QTL and suggested the presence of at least one causal gene. Haplotype mapping reduced the critical region of the distal part of the QTL to 31 Mbp containing the potential candidates Nr1i3, Apoa2, Atp1a2, Prox1, and Hsd11b1. We conclude that obesity and hyperglycemia of NZO is to a large part caused by variant genes located in Nob3 on chromosome 1. Since these exert robust effects on a B6 background, the QTL Nob3 is a prime target for identification of a novel diabesity gene.

positional cloning; metabolic syndrome; diabetes; cholesterol; New Zealand obese mouse







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.